DJ Novavax Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. $(NVAX)$ advanced 1.19% to $9.37 Monday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 0.12% to 26,370.89 and Dow Jones Industrial Average falling 0.70% to 53,185.90.
This was the stock's second consecutive day of gains.
Novavax Inc. closed 21.72% below its 52-week high of $11.97, which the company achieved on February 26th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ fell 0.82% to $265.85, Pfizer Inc. $(PFE)$ rose 1.79% to $28.46, and Merck & Co. Inc. (MRK) fell 0.40% to $147.76.
Trading volume (7.3 M) eclipsed its 50-day average volume of 4.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 31, 2026.